Genesis HealthCare (GEN) Tops Q4 EPS by 1c; offers guidance

Genesis HealthCare (NASDAQ: GEN) reported Q4 EPS of $0.59, $0.01 better than the analyst estimate of $0.58. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $995.97 million.

GUIDANCE:

Genesis HealthCare sees Q1 2026 EPS of $0.59-$0.61, versus the consensus of $0.58. Genesis HealthCare sees Q1 2026 revenue of $1180-1210 million, versus the consensus of $996.3 million.

Genesis HealthCare sees FY2026 EPS of $2.46-$2.54, versus the consensus of $2.42. Genesis HealthCare sees FY2026 revenue of $4.7-4.8 billion, versus the consensus of $4.052 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Obsidian Energy Increases Syndicated Credit Facility
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance